OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Actionable mutations in canine hemangiosarcoma
Guannan Wang, Ming‐Fang Wu, Martha A. MaloneyHuss, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0188667-e0188667
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies
Natália Nosálová, Mykhailo Huniadi, Ľubica Horňáková, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2891-2891
Open Access | Times Cited: 15

Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma
Kate Megquier, Jason Turner-Maier, Ross Swofford, et al.
Molecular Cancer Research (2019) Vol. 17, Iss. 12, pp. 2410-2421
Open Access | Times Cited: 100

Canine sarcomas as a surrogate for the human disease
Daniel L. Gustafson, Dawn L. Duval, Daniel P. Regan, et al.
Pharmacology & Therapeutics (2018) Vol. 188, pp. 80-96
Open Access | Times Cited: 71

Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma
Guannan Wang, Ming‐Fang Wu, Amy C. Durham, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0229728-e0229728
Open Access | Times Cited: 47

Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics
Lucas Rodrigues, Joshua Watson, Feng Yuan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13

Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future
Heike Aupperle‐Lellbach, Alexandra Kehl, Simone de Brot, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 5, pp. 199-199
Open Access | Times Cited: 5

Somatic Mutation of PIK3CA (H1047R) Is a Common Driver Mutation Hotspot in Canine Mammary Tumors as Well as Human Breast Cancers
Kang-Hoon Lee, Hyeon‐Ji Hwang, Hyun Ji Noh, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 2006-2006
Open Access | Times Cited: 42

Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis
Supratim Mandal, Shrabasti Bandyopadhyay, Komal Tyagi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188619-188619
Closed Access | Times Cited: 31

Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma
Kim Wong, Latasha Ludwig, Oscar Krijgsman, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 7
Open Access | Times Cited: 27

Review: NF-kB activation in canine cancer
Lisa J. Schlein, Douglas H. Thamm
Veterinary Pathology (2022) Vol. 59, Iss. 5, pp. 724-732
Closed Access | Times Cited: 20

Precision Medicine in Veterinary Science
Esther Chon, William P.D. Hendricks, Michelle E. White, et al.
Veterinary Clinics of North America Small Animal Practice (2024) Vol. 54, Iss. 3, pp. 501-521
Closed Access | Times Cited: 4

Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion
Jong Hyuk Kim, Ashley J. Schulte, Aaron L. Sarver, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 4

Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients
Shukmei Wong, E. J. Ehrhart, Samuel D. Stewart, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0264986-e0264986
Open Access | Times Cited: 18

Novel genomic prognostic biomarkers for dogs with cancer
Esther Chon, Sharadha Sakthikumar, Min Tang, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 6, pp. 2410-2421
Open Access | Times Cited: 9

Personalized medicine: going to the dogs?
Katrina L. Mealey, Stephanie E. Martinez, Nicolás F. Villarino, et al.
Human Genetics (2019) Vol. 138, Iss. 5, pp. 467-481
Closed Access | Times Cited: 28

Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing
Sunetra Das, Rupa Idate, Kathryn E. Cronise, et al.
Molecular Cancer Therapeutics (2019) Vol. 18, Iss. 8, pp. 1460-1471
Open Access | Times Cited: 28

Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions
Jong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 5, pp. 847-861
Open Access | Times Cited: 22

Canine models of human cancer: Bridging the gap to improve precision medicine
Rebecca L. Nance, Abdul Mohin Sajib, B. F. Smith
Progress in molecular biology and translational science (2022), pp. 67-99
Closed Access | Times Cited: 15

Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma
Timothy Estabrooks, Anastasia Gurinovich, Jodie Pietruska, et al.
Veterinary and Comparative Oncology (2023) Vol. 21, Iss. 4, pp. 623-633
Open Access | Times Cited: 8

Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential
Sharadha Sakthikumar, Manisha Warrier, Derick Whitley, et al.
Veterinary and Comparative Oncology (2023) Vol. 22, Iss. 1, pp. 30-41
Open Access | Times Cited: 7

The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification
Antonella Fanelli, Luca Licenziato, Eugenio Mazzone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Canine Cutaneous Haemangiosarcoma: Biomarkers and Survival
Daniela Farias da Nóbrega, Vanessa Ferreira Sehaber, Renata Cunha Madureira, et al.
Journal of Comparative Pathology (2018) Vol. 166, pp. 87-96
Closed Access | Times Cited: 21

In vitro anticancer effects of alpelisib against PIK3CA‑mutated canine hemangiosarcoma cell lines
Marika Maeda, Kazuhiko Ochiai, Masaki Michishita, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top